IQVIA Holdings Inc.
IQV
Kedudukan dalam Saham
#556
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Harga Saham
$267.20
Modal Pasaran
$43.98B
Perubahan (1 hari)
0.50%
Perubahan (1 tahun)
26.01%
Negara
US
Perdagangan IQVIA Holdings Inc. (IQV)
Kategori
Healthcare
Bilangan saham terbitan bagi IQVIA Holdings Inc. (IQV)
Bilangan saham terbitan setakat June 2026: 167.20M
Menurut laporan kewangan terkini dan harga saham IQVIA Holdings Inc., bilangan saham terbitan semasa ialah 167.20M. Pada akhir December 2024, syarikat mempunyai 181.30M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk IQVIA Holdings Inc. (IQV) dari 2010 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 167.20M | -2.73% |
| 2025 | 171.90M | -5.18% |
| 2024 | 181.30M | -1.36% |
| 2023 | 183.80M | -2.03% |
| 2022 | 187.60M | -1.99% |
| 2021 | 191.40M | 0.05% |
| 2020 | 191.30M | -1.95% |
| 2019 | 195.10M | -4.22% |
| 2018 | 203.70M | -6.47% |
| 2017 | 217.80M | 46.08% |
| 2016 | 149.10M | 21.18% |
| 2015 | 123.04M | -3.87% |
| 2014 | 127.99M | 3.10% |
| 2013 | 124.15M | -1.05% |
| 2012 | 125.47M | 0.00% |
| 2011 | 125.47M | 0.00% |
| 2010 | 125.47M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 371.00M | 121.89% |
US
|
|
| 705.30M | 321.83% |
US
|
|
| 143.28M | -14.31% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 68.66% |
US
|
